Cat. No.: X22-05-ZQ206
Gensenoside Rh7
Synonym: 343780-68-7; GensenosideRh7; Ginsenoside Rh7; (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,7S,8R,9R,10R,12R,13R,14R,17S)-3,7,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,7,9,11,12,13,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol
- CAS Number: 343780-68-7
- Compound CID: 101096472
Product Size
10 mg; 20 mg; 50 mg; 100 mg
Properties
Description
Ginsenoside Rh7 is a saponin that has shown anti-tumor effects, which are mediated by its ability to inhibit cancer cell proliferation and induce apoptosis. Ginsenoside Rh7 also has an effect on the skeleton, including bone formation, cellular function, and mineralization. Ginsenoside Rh7 has been shown to have bioinformatics-mediated antitumor effects on lung cancer cells. This product is widely used in research in the fields of pharmaceuticals, cosmetics and health products.
Molecular Formula
C36H60O9
Purity
≥95%, determined by HPLC.
Solubility
It is soluble in methanol.
Identity
Confirmed by MS and NMR.
Applications
Gensenoside Rh7 is widely used in research in the fields of pharmaceuticals, cosmetics and health products.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products
